{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T22:13:05Z","timestamp":1779142385626,"version":"3.51.4"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,5,18]]},"DOI":"10.7759\/cureus.109138","type":"journal-article","created":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T21:36:26Z","timestamp":1779140186000},"source":"Crossref","is-referenced-by-count":0,"title":["Use of Artificial Intelligence for the Early Detection and Prediction of Alzheimer\u2019s Disease"],"prefix":"10.7759","author":[{"given":"Lhakpa T","family":"Khangsar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew J","family":"Boileau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jalz.2011.03.005","article-title":"The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease","volume":"7","author":"McKhann GM","year":"2011","unstructured":"McKhann GM, Knopman DS, Chertkow H, et al.. The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement. 2011, 7:263-9. 10.1016\/j.jalz.2011.03.005","journal-title":"Alzheimers Dement"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1002\/alz.70235","article-title":"2025 Alzheimer's disease facts and figures","volume":"21","year":"2025","unstructured":"2025 Alzheimer's disease facts and figures. Alzheimers Dement. 2025, 21.e70235. 10.1002\/alz.70235","journal-title":"Alzheimers Dement"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.2174\/1570159X18666200528142429","article-title":"Recent advancements in pathogenesis, diagnostics and treatment of Alzheimer's disease","volume":"18","author":"Khan S","year":"2020","unstructured":"Khan S, Barve KH, Kumar MS. Recent advancements in pathogenesis, diagnostics and treatment of Alzheimer's disease. Curr Neuropharmacol. 2020, 18:1106-25. 10.2174\/1570159X18666200528142429","journal-title":"Curr Neuropharmacol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.14283\/jpad.2021.23","article-title":"Diagnosis of early Alzheimer's disease: clinical practice in 2021","volume":"8","author":"Porsteinsson AP","year":"2021","unstructured":"Porsteinsson AP, Isaacson RS, Knox S, Sabbagh MN, Rubino I. Diagnosis of early Alzheimer's disease: clinical practice in 2021. J Prev Alzheimers Dis. 2021, 8:371-86. 10.14283\/jpad.2021.23","journal-title":"J Prev Alzheimers Dis"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24076518","article-title":"Inflammatory processes in Alzheimer's disease: pathomechanism, diagnosis and treatment: a review","volume":"24","author":"Twarowski B","year":"2023","unstructured":"Twarowski B, Herbet M. Inflammatory processes in Alzheimer's disease: pathomechanism, diagnosis and treatment: a review. Int J Mol Sci. 2023, 24:6518. 10.3390\/ijms24076518","journal-title":"Int J Mol Sci"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.mcna.2018.10.009","article-title":"The Alzheimer's disease clinical spectrum: diagnosis and management","volume":"103","author":"Atri A","year":"2019","unstructured":"Atri A. The Alzheimer's disease clinical spectrum: diagnosis and management. Med Clin North Am. 2019, 103:263-93. 10.1016\/j.mcna.2018.10.009","journal-title":"Med Clin North Am"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1046\/j.1525-1497.2001.016009606.x","article-title":"The PHQ-9: validity of a brief depression severity measure","volume":"16","author":"Kroenke K","year":"2001","unstructured":"Kroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med. 2001, 16:606-13. 10.1046\/j.1525-1497.2001.016009606.x","journal-title":"J Gen Intern Med"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.3233\/JAD-140276","article-title":"Neuropsychological criteria for mild cognitive impairment improves diagnostic precision, biomarker associations, and progression rates","volume":"42","author":"Bondi MW","year":"2014","unstructured":"Bondi MW, Edmonds EC, Jak AJ, et al.. Neuropsychological criteria for mild cognitive impairment improves diagnostic precision, biomarker associations, and progression rates. J Alzheimers Dis. 2014, 42:275-89. 10.3233\/JAD-140276","journal-title":"J Alzheimers Dis"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.140.6.566","article-title":"A new clinical scale for the staging of dementia","volume":"140","author":"Hughes CP","year":"1982","unstructured":"Hughes CP, Berg L, Danziger WL, Coben LA, Martin RL. A new clinical scale for the staging of dementia. Br J Psychiatry. 1982, 140:566-72. 10.1192\/bjp.140.6.566","journal-title":"Br J Psychiatry"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(20)30440-3","article-title":"New insights into atypical Alzheimer's disease in the era of biomarkers","volume":"20","author":"Graff-Radford J","year":"2021","unstructured":"Graff-Radford J, Yong KX, Apostolova LG, et al.. New insights into atypical Alzheimer's disease in the era of biomarkers. Lancet Neurol. 2021, 20:222-34. 10.1016\/S1474-4422(20)30440-3","journal-title":"Lancet Neurol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1002\/ana.26894","article-title":"Increased cortical thickness in Alzheimer's disease","volume":"95","author":"Phan TX","year":"2024","unstructured":"Phan TX, Baratono S, Drew W, Tetreault AM, Fox MD, Darby RR. Increased cortical thickness in Alzheimer's disease. Ann Neurol. 2024, 95:929-40. 10.1002\/ana.26894","journal-title":"Ann Neurol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2021.101416","article-title":"Olfactory dysfunction in aging and neurodegenerative diseases","volume":"70","author":"Dan X","year":"2021","unstructured":"Dan X, Wechter N, Gray S, Mohanty JG, Croteau DL, Bohr VA. Olfactory dysfunction in aging and neurodegenerative diseases. Ageing Res Rev. 2021, 70:101416. 10.1016\/j.arr.2021.101416","journal-title":"Ageing Res Rev"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.3390\/healthcare10030541","article-title":"Machine-learning-based disease diagnosis: a comprehensive review","volume":"10","author":"Ahsan MM","year":"2022","unstructured":"Ahsan MM, Luna SA, Siddique Z. Machine-learning-based disease diagnosis: a comprehensive review. Healthcare (Basel). 2022, 10:541. 10.3390\/healthcare10030541","journal-title":"Healthcare (Basel)"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1148\/rg.2017160130","article-title":"Machine learning for medical imaging","volume":"37","author":"Erickson BJ","year":"2017","unstructured":"Erickson BJ, Korfiatis P, Akkus Z, Kline TL. Machine learning for medical imaging. Radiographics. 2017, 37:505-15. 10.1148\/rg.2017160130","journal-title":"Radiographics"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2020.03.022","article-title":"How machine learning will transform Biomedicine","volume":"181","author":"Goecks J","year":"2020","unstructured":"Goecks J, Jalili V, Heiser LM, Gray JW. How machine learning will transform Biomedicine. Cell. 2020, 181:92-101. 10.1016\/j.cell.2020.03.022","journal-title":"Cell"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1109\/ACCESS.2021.3062484","article-title":"Machine learning and deep learning approaches for brain disease diagnosis: principles and recent advances","volume":"9","author":"Khan P","year":"2021","unstructured":"Khan P, Kader MF, Islam SMR, Kamal MS, Toha MU, Kwak KS, Rahman AB. Machine learning and deep learning approaches for brain disease diagnosis: principles and recent advances. IEEE Access. 2021, 9:37622-55. 10.1109\/ACCESS.2021.3062484","journal-title":"IEEE Access"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-22277-x","article-title":"Machine learning-based individual assessment of cortical atrophy pattern in Alzheimer's disease spectrum: development of the classifier and longitudinal evaluation","volume":"8","author":"Lee JS","year":"2018","unstructured":"Lee JS, Kim C, Shin JH, et al.. Machine learning-based individual assessment of cortical atrophy pattern in Alzheimer's disease spectrum: development of the classifier and longitudinal evaluation. Sci Rep. 2018, 8:4161. 10.1038\/s41598-018-22277-x","journal-title":"Sci Rep"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-155-8-201110180-00009","article-title":"QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies","volume":"155","author":"Whiting PF","year":"2011","unstructured":"Whiting PF, Rutjes AW, Westwood ME, et al.. QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies. Ann Intern Med. 2011, 155:529-36. 10.7326\/0003-4819-155-8-201110180-00009","journal-title":"Ann Intern Med"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.26355\/eurrev_202211_30122","article-title":"Classification of Alzheimer's disease stage using machine learning for left and right oxygenation difference signals in the prefrontal cortex: a patient-level, single-group, diagnostic interventional trial","volume":"26","author":"Kim J","year":"2022","unstructured":"Kim J, Kim SC, Kang D, Yon DK, Kim JG. Classification of Alzheimer's disease stage using machine learning for left and right oxygenation difference signals in the prefrontal cortex: a patient-level, single-group, diagnostic interventional trial. Eur Rev Med Pharmacol Sci. 2022, 26:7734-41. 10.26355\/eurrev_202211_30122","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1186\/s13195-023-01268-9","article-title":"Quantification of identifying cognitive impairment using olfactory-stimulated functional near-infrared spectroscopy with machine learning: a post hoc analysis of a diagnostic trial and validation of an external additional trial","volume":"15","author":"Kim J","year":"2023","unstructured":"Kim J, Lee H, Lee J, et al.. Quantification of identifying cognitive impairment using olfactory-stimulated functional near-infrared spectroscopy with machine learning: a post hoc analysis of a diagnostic trial and validation of an external additional trial. Alzheimers Res Ther. 2023, 15:127. 10.1186\/s13195-023-01268-9","journal-title":"Alzheimers Res Ther"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.3390\/bios12090753","article-title":"The feasibility of early Alzheimer's disease diagnosis using a neural network hybrid platform","volume":"12","author":"Yu X","year":"2022","unstructured":"Yu X, Srivastava S, Huang S, Hayden EY, Teplow DB, Xie YH. The feasibility of early Alzheimer's disease diagnosis using a neural network hybrid platform. Biosensors (Basel). 2022, 12:753. 10.3390\/bios12090753","journal-title":"Biosensors (Basel)"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1001\/archneur.56.3.303","article-title":"Mild cognitive impairment: clinical characterization and outcome","volume":"56","author":"Petersen RC","year":"1999","unstructured":"Petersen RC, Smith GE, Waring SC, Ivnik RJ, Tangalos EG, Kokmen E. Mild cognitive impairment: clinical characterization and outcome. Arch Neurol. 1999, 56:303-8. 10.1001\/archneur.56.3.303","journal-title":"Arch Neurol"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1176\/appi.books.9780890420614.dsm-iv","article-title":"Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV)","year":"1994","unstructured":"Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV). American Psychiatric Association, Washington, DC; 1994. 10.1176\/appi.books.9780890420614.dsm-iv"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1212\/wnl.34.7.939","article-title":"Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease","volume":"34","author":"McKhann G","year":"1984","unstructured":"McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology. 1984, 34:939-44. 10.1212\/wnl.34.7.939","journal-title":"Neurology"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.2174\/1567205020666221019122049","article-title":"Machine-based learning shifting to prediction model of deteriorative MCI due to Alzheimer's disease: a two-year follow-up investigation","volume":"19","author":"Zhao X","year":"2022","unstructured":"Zhao X, Sui H, Yan C, Zhang M, Song H, Liu X, Yang J. Machine-based learning shifting to prediction model of deteriorative MCI due to Alzheimer's disease: a two-year follow-up investigation. Curr Alzheimer Res. 2022, 19:708-15. 10.2174\/1567205020666221019122049","journal-title":"Curr Alzheimer Res"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.139.9.1136","article-title":"The Global Deterioration Scale for assessment of primary degenerative dementia","volume":"139","author":"Reisberg B","year":"1982","unstructured":"Reisberg B, Ferris SH, de Leon MJ, Crook T. The Global Deterioration Scale for assessment of primary degenerative dementia. Am J Psychiatry. 1982, 139:1136-9. 10.1176\/ajp.139.9.1136","journal-title":"Am J Psychiatry"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-82098-3","article-title":"A multilayer multimodal detection and prediction model based on explainable artificial intelligence for Alzheimer's disease","volume":"11","author":"El-Sappagh S","year":"2021","unstructured":"El-Sappagh S, Alonso JM, Islam SM, Sultan AM, Kwak KS. A multilayer multimodal detection and prediction model based on explainable artificial intelligence for Alzheimer's disease. Sci Rep. 2021, 11:2660. 10.1038\/s41598-021-82098-3","journal-title":"Sci Rep"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1093\/geronj\/37.3.323","article-title":"Measurement of functional activities in older adults in the community","volume":"37","author":"Pfeffer RI","year":"1982","unstructured":"Pfeffer RI, Kurosaki TT, Harrah CH Jr, Chance JM, Filos S. Measurement of functional activities in older adults in the community. J Gerontol. 1982, 37:323-9. 10.1093\/geronj\/37.3.323","journal-title":"J Gerontol"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1136\/bmj-2023-078378","article-title":"TRIPOD+AI statement: updated guidance for reporting clinical prediction models that use regression or machine learning methods","volume":"385","author":"Collins GS","year":"2024","unstructured":"Collins GS, Moons KG, Dhiman P, et al.. TRIPOD+AI statement: updated guidance for reporting clinical prediction models that use regression or machine learning methods. BMJ. 2024, 385:e078378. 10.1136\/bmj-2023-078378","journal-title":"BMJ"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1136\/bmj-2024-082505","article-title":"PROBAST+AI: an updated quality, risk of bias, and applicability assessment tool for prediction models using regression or artificial intelligence methods","volume":"388","author":"Moons KG","year":"2025","unstructured":"Moons KG, Damen JA, Kaul T, et al.. PROBAST+AI: an updated quality, risk of bias, and applicability assessment tool for prediction models using regression or artificial intelligence methods. BMJ. 2025, 388:e082505. 10.1136\/bmj-2024-082505","journal-title":"BMJ"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-021-01517-0","article-title":"A quality assessment tool for artificial intelligence-centered diagnostic test accuracy studies: QUADAS-AI","volume":"27","author":"Sounderajah V","year":"2021","unstructured":"Sounderajah V, Ashrafian H, Rose S, et al.. A quality assessment tool for artificial intelligence-centered diagnostic test accuracy studies: QUADAS-AI. Nat Med. 2021, 27:1663-5. 10.1038\/s41591-021-01517-0","journal-title":"Nat Med"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/487888-use-of-artificial-intelligence-for-the-early-detection-and-prediction-of-alzheimers-disease","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T21:36:27Z","timestamp":1779140187000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/487888-use-of-artificial-intelligence-for-the-early-detection-and-prediction-of-alzheimers-disease"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,18]]},"references-count":31,"URL":"https:\/\/doi.org\/10.7759\/cureus.109138","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5,18]]}}}